NCT04773002

Brief Summary

In this study, investigators wanted to investigate the effect of volatile anesthesia and total intravenous anesthesia (TIVA) on ecchymosis, edema, and intraoperative bleeding in rhinoplasty.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
52

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2021

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 26, 2021

Completed
20 days until next milestone

Study Start

First participant enrolled

March 18, 2021

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 21, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 21, 2021

Completed
Last Updated

March 16, 2022

Status Verified

March 1, 2022

Enrollment Period

5 months

First QC Date

February 23, 2021

Last Update Submit

March 15, 2022

Conditions

RhinoplastyEcchymosisEdemaHemorrhage

Outcome Measures

Primary Outcomes (1)

  • Edema and ecchymosis in rhinoplasty according to the type of anesthesia.

    It is evaluation developing edema and ecchymosis according to total intravenous anesthesia and volatile anesthesia in rhinoplasty.

    one time in six months

Study Arms (2)

Group P

Total intravenous anesthesia (TIVA)

Other: Different anesthesia methods

Group S

Volatile anestesia

Other: Different anesthesia methods

Interventions

Different anesthesia methodsOTHER

Total intravenous anesthesia (TIVA)and volatile anesthesia

Group PGroup S

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Rhinoplasty patients

You may qualify if:

  • Between 18 and 65 years
  • Planned to rhinoplasty
  • An American Society of Anesthesiologists score of 1 or 2

You may not qualify if:

  • Steroid use
  • Patients with coagulation disorders, •Rejected to participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gaziosmanpasa University

Tokat Province, 60200, Turkey (Türkiye)

Location

MeSH Terms

Conditions

EcchymosisEdemaHemorrhage

Condition Hierarchy (Ancestors)

Blood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsSkin ManifestationsSigns and Symptoms

Study Officials

  • Muzaffer Katar

    Gaziosmanpasa university

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

February 23, 2021

First Posted

February 26, 2021

Study Start

March 18, 2021

Primary Completion

August 21, 2021

Study Completion

August 21, 2021

Last Updated

March 16, 2022

Record last verified: 2022-03

Locations

TU(1)